These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38768417)

  • 21. How use of continuous glucose monitoring can address therapeutic inertia in primary care.
    Martens TW; Parkin CG
    Postgrad Med; 2022 Aug; 134(6):576-588. PubMed ID: 35584802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous Glucose Monitoring in the Real World Using Photosurveillance of #Dexcom on Instagram: Exploratory Mixed Methods Study.
    Litchman ML; Wawrzynski SE; Woodruff WS; Arrington JB; Nguyen QC; Gee PM
    JMIR Public Health Surveill; 2019 May; 5(2):e11024. PubMed ID: 31127724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the Dexcom G6 Continuous Glucose Monitoring System in Pregnant Women with Diabetes.
    Castorino K; Polsky S; O'Malley G; Levister C; Nelson K; Farfan C; Brackett S; Puhr S; Levy CJ
    Diabetes Technol Ther; 2020 Dec; 22(12):943-947. PubMed ID: 32324061
    [No Abstract]   [Full Text] [Related]  

  • 24. Validity of continuous glucose monitoring for categorizing glycemic responses to diet: implications for use in personalized nutrition.
    Merino J; Linenberg I; Bermingham KM; Ganesh S; Bakker E; Delahanty LM; Chan AT; Capdevila Pujol J; Wolf J; Al Khatib H; Franks PW; Spector TD; Ordovas JM; Berry SE; Valdes AM
    Am J Clin Nutr; 2022 Jun; 115(6):1569-1576. PubMed ID: 35134821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.
    Klarskov CK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
    Trials; 2020 Nov; 21(1):968. PubMed ID: 33239100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
    DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
    Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: Real-world data.
    Kant R; Antony MA; Geurkink D; Gilreath N; Chandra L; Zipprer E; Munir KM; Chandra R; Parker VG; Verma V
    Prim Care Diabetes; 2022 Dec; 16(6):786-790. PubMed ID: 36117090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy.
    Nemlekar PM; Hannah KL; Green CR; Norman GJ
    Diabetes Ther; 2024 Mar; 15(3):639-648. PubMed ID: 38289464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study.
    DeSalvo DJ; Noor N; Xie C; Corathers SD; Majidi S; McDonough RJ; Polsky S; Izquierdo R; Rioles N; Weinstock R; Obrynba K; Roberts A; Vendrame F; Sanchez J; Ebekozien O
    J Diabetes Sci Technol; 2023 Mar; 17(2):322-328. PubMed ID: 34632823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada.
    Roze S; Isitt JJ; Smith-Palmer J; Lynch P
    Clinicoecon Outcomes Res; 2021; 13():717-725. PubMed ID: 34408456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycemic variability and indices of glycemic control among pregnant women with type 1 diabetes (T1D) based on the use of continuous glucose monitoring share technology.
    Sklar J; Pyle L; Snell-Bergeon JK; Garcetti R; Joshee P; Demmitt JK; Polsky S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8968-8974. PubMed ID: 34875947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
    Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
    Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
    Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in Diabetes-Related Hospitalizations and Medical Costs After Dexcom G6 Continuous Glucose Monitor Initiation in People with Type 2 Diabetes Using Intensive Insulin Therapy.
    Hannah KL; Nemlekar PM; Green CR; Norman GJ
    Adv Ther; 2024 Jun; 41(6):2299-2306. PubMed ID: 38619722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.
    Chan CL
    Curr Diab Rep; 2017 Sep; 17(9):66. PubMed ID: 28726154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring.
    Gal RL; Cohen NJ; Kruger D; Beck RW; Bergenstal RM; Calhoun P; Cushman T; Haban A; Hood K; Johnson ML; McArthur T; Olson BA; Weinstock RS; Oser SM; Oser TK; Bugielski B; Strayer H; Aleppo G
    J Endocr Soc; 2020 Sep; 4(9):bvaa076. PubMed ID: 32864542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
    Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
    Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.